Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Sales Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Sales Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Net Sales Growth(%) 12.771.98-5.8612.442.85

What is the latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Sales Growth ratio of GLENMARK PHARMACEUTICALS is 12.77 based on Mar2025 Consolidated results.
Year Net Sales Growth
Mar202512.77
Mar20241.98
Mar2023-5.86
Mar202212.44
Mar20212.85

How is Net Sales Growth of GLENMARK PHARMACEUTICALS Trending?

Years Net Sales Growth % Change
Mar2025 12.77
544.95
Mar2024 1.98
Positive
Mar2023 -5.86
Negative
Mar2022 12.44
336.49
Mar2021 2.85 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Net Sales Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,529.3 Cr 3.7% 10.5% 30.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,982.0 Cr -0.7% -0.5% -3.1% Stock Analytics
DIVIS LABORATORIES ₹172,878.0 Cr 2.8% 2.2% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,095.0 Cr 1.5% 3.4% 12.4% Stock Analytics
CIPLA ₹122,175.0 Cr 0.8% 0.1% 3.1% Stock Analytics
DR REDDYS LABORATORIES ₹107,154.0 Cr 0.4% 3.2% 0.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

3.7%

10.5%

30.6%

SENSEX

0.4%

-0.1%

6.1%


You may also like the below Video Courses